Clinical Trial Update: Efficacy and Safety Study of Uracyst to Treat Interstitial Cystitis/Painful Bladder Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial of Uracyst for treating Interstitial Cystitis and Painful Bladder Syndrome has been completed with results posted in 2013 evaluating efficacy and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Cystitis
• Painful Bladder Syndrome

Drugs mentioned

• Uracyst (sodium hyaluronate)

Snippet

Sponsor: Watson Pharmaceuticals | Conditions: Interstitial Cystitis, Painful Bladder Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2013-05-03